All Pharma News
Eli Lilly`s Jaypirca gets US nod for mantle cell lymphoma

Eli Lilly`s Jaypirca gets US nod for mantle cell lymphoma
Kyle LaHucik ENDPTS
28 Jan 2023
Share Share
Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review

Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review
ENDPTS
12 Dec 2022
Share Share
Lilly, Foghorn Collaborate for Novel Oncology Targets Using Gene Traffic Control

Lilly, Foghorn Collaborate for Novel Oncology Targets Using Gene Traffic Control
PRNEWSWIRE
13 Dec 2021
Share Share
Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC

Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC
PRNEWSWIRE
07 Oct 2021
Share Share
Lilly and Kumquat Biosciences Discover and Develop Novel Small Molecules

Lilly and Kumquat Biosciences Discover and Develop Novel Small Molecules
PRNEWSWIRE
29 Jul 2021
Share Share
Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305)

Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305)
PRNEWSWIRE
05 Mar 2021
Share Share
Lilly cancer R&D chief Bilenker quits, handing reins to deputy

Lilly cancer R&D chief Bilenker quits, handing reins to deputy
A.Al Idrus FIERCE BIOTECH
03 Feb 2021
Share Share
Eli Lilly`s new cancer R&D chief has some things to say about drug discovery

Eli Lilly`s new cancer R&D chief has some things to say about drug discovery
John Carroll ENDPTS
02 Feb 2021
Share Share
Josh Bilenker ends his brief role in an unusual experiment at Eli Lilly, bowing

Josh Bilenker ends his brief role in an unusual experiment at Eli Lilly, bowing
John Carroll ENDPTS
29 Jan 2021
Share Share
Lilly expands its cancer drug work with bet on dual-acting antibodies

Lilly expands its cancer drug work with bet on dual-acting antibodies
Ben Fidler BIOPHARMADIVE
20 Jan 2021
Share Share